SCHEMBL30101459

SCHEMBL30101459

c1cc2c(c(NC3CCCOC3)c1)CNC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TIPARP Q7Z3E1 2/20 0.46
KAT2B Q92831 1/20 0.37
IDH1 O75874 1/20 0.37
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36
MKNK1 Q9BUB5 3/20 0.36
MKNK2 Q9HBH9 3/20 0.36
NAMPT P43490 1/20 0.34
GBA1 P04062 1/20 0.34
PIM1 P11309 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
PRMT5 O14744 1/20 0.33
WDR77 Q9BQA1 1/20 0.33
BTK Q06187 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
CXCR4 P61073 2/20 0.32
CNR2 P34972 1/20 0.32
LTA4H P09960 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24913826 1.00 TIPARP (0.46) TIPARPKAT2BIDH1JAK2JAK1
SCHEMBL31062487 0.93 TIPARP (0.40) TIPARPMKNK1MKNK2NAMPT
SCHEMBL24913959 0.93 TIPARP (0.40) TIPARPMKNK1MKNK2NAMPT
SCHEMBL24914238 0.93 TIPARP (0.40) TIPARPMKNK1MKNK2NAMPT
Hydrochloric Acid SCHEMBL29008591 0.92 TIPARP (0.39) TIPARPMKNK1MKNK2NAMPT
Hydrochloric Acid SCHEMBL31013858 0.92 TIPARP (0.39) TIPARPMKNK1MKNK2NAMPT
Hydrochloric Acid SCHEMBL31013987 0.92 TIPARP (0.39) TIPARPMKNK1MKNK2NAMPT
Hydrochloric Acid SCHEMBL30156740 0.92 TIPARP (0.39) TIPARPMKNK1MKNK2NAMPT
SCHEMBL24913935 0.87 TIPARP (0.34) TIPARPBTKCXCR4
SCHEMBL31062485 0.87 TIPARP (0.34) TIPARPBTKCXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250034120-A1 PYRIDAZINONES AS PARP7 INHIBITORS RIBON THERAPEUTICS, INC. 2025-01-30 US disclosed
US-20240293392-A1 INHIBITOR COMPOUNDS Neophore Limited (GB) 2024-09-05 US disclosed
US-20230192664-A1 PYRIDAZINONES AS PARP7 INHIBITORS ANKURA TRUST COMPANY, LLC, AS COLLATERAL TRUSTEE 2023-06-22 US disclosed
US-11566020-B1 Pyridazinones as PARP7 inhibitors RIBON THERAPEUTICS, INC. (US) 2023-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240293392-A1 INHIBITOR COMPOUNDS MSH2, PMS2, MSH6 TIPARP 1544/4885KAT2B 3146/4885IDH1 220/4885
US-20250034120-A1 PYRIDAZINONES AS PARP7 INHIBITORS PARP2, PARP1, PARP4 TIPARP 152/4885KAT2B 1487/4885IDH1 348/4885
US-11566020-B1 Pyridazinones as PARP7 inhibitors PARP2, PARP1, PARP4 TIPARP 152/4885KAT2B 1487/4885IDH1 348/4885
US-20230192664-A1 PYRIDAZINONES AS PARP7 INHIBITORS PARP2, PARP1, PARP4 TIPARP 152/4885KAT2B 1487/4885IDH1 348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.